Literature DB >> 11856073

Non-surgical treatment of hepatocellular carcinoma.

A M Alsowmely1, H J F Hodgson.   

Abstract

Primary hepatocellular cancer is a disease with a poor prognosis for which there is little consensus on treatment and a paucity of comparative trials. The coexistence of cancer with cirrhosis complicates treatment, and also confers a high risk for the development of further tumours. Surgery, either by hepatic resection or orthotopic liver transplantation, is only a feasible option in a minority of patients. This article surveys the non-surgical approaches to the treatment of hepatocellular cancers-local ablation techniques, arterial embolization with and without chemotherapy, conventional chemotherapy and hormonal modulation, and targeted and external irradiation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11856073     DOI: 10.1046/j.1365-2036.2002.01149.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  19 in total

1.  Combined transarterial chemoembolization and arterial administration of Bletilla striata in treatment of liver tumor in rats.

Authors:  Jun Qian; Daryusch Vossoughi; Dirk Woitaschek; Elsie Oppermann; Wolf O Bechstein; Wei-Yong Li; Gan-Sheng Feng; Thomas Vogl
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

2.  Detection of hypervascular hepatocellular carcinoma: Comparison of multi-detector CT with digital subtraction angiography and Lipiodol CT.

Authors:  Xiao-Hua Zheng; Yong-Song Guan; Xiang-Ping Zhou; Juan Huang; Long Sun; Xiao Li; Yuan Liu
Journal:  World J Gastroenterol       Date:  2005-01-14       Impact factor: 5.742

3.  Simultaneous injection of autologous mononuclear cells with TACE in HCC patients; preliminary study.

Authors:  Alaa Ismail; Ahmed AlDorry; Mohammed Shaker; Reda Elwekeel; Khaled Mokbel; Doaa Zakaria; Anas Meshaal; Firas Zahr Eldeen; Abdulhafez Selim
Journal:  J Gastrointest Cancer       Date:  2011-03

Review 4.  Preventive treatments for recurrence after curative resection of hepatocellular carcinoma--a literature review of randomized control trials.

Authors:  Hui-Chuan Sun; Zhao-You Tang
Journal:  World J Gastroenterol       Date:  2003-04       Impact factor: 5.742

5.  Colchicine sensitizes human hepatocellular carcinoma cells to damages caused by radiation.

Authors:  Chia-Yuan Liu; Hui-Fen Liao; Shou-Chuan Shih; Shee-Chan Lin; Wen-Hsiung Chang; Cheng-Hsin Chu; Tsang-En Wang; Yu-Jen Chen
Journal:  World J Gastroenterol       Date:  2005-07-21       Impact factor: 5.742

Review 6.  Combined interventional therapies of hepatocellular carcinoma.

Authors:  Jun Qian; Gan-Sheng Feng; Thomas Vogl
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

7.  Role and limitation of FMPSPGR dynamic contrast scanning in the follow-up of patients with hepatocellular carcinoma treated by TACE.

Authors:  Fu-Hua Yan; Kang-Rong Zhou; Jie-Min Cheng; Jian-Hua Wang; Zhi-Ping Yan; Reng-Rong Da; Jia Fan; Yuan Ji
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

8.  Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE).

Authors:  R Iezzi; V Cesario; L Siciliani; M Campanale; A M De Gaetano; M Siciliano; S Agnes; F Giuliante; A Grieco; M Pompili; G L Rapaccini; A Gasbarrini; L Bonomo
Journal:  Radiol Med       Date:  2013-01-28       Impact factor: 3.469

9.  Therapeutic efficacy of brucea javanica oil emulsion (BJOE) combined with transcatheter hepatic arterial chemoembolization (TACE) in patients with primary liver cancer.

Authors:  Wei Jin; Haiming Han; Shulong Zhou; Yingchao Wang; Tao Dong; Cunxin Zhao
Journal:  Int J Clin Exp Med       Date:  2015-10-15

10.  Trans-arterial gene therapy for hepatocellular carcinoma in a rabbit model.

Authors:  Tao Gu; Cai-Xia Li; Yan Feng; Qian Wang; Chun-Hai Li; Chuan-Fu Li
Journal:  World J Gastroenterol       Date:  2007-04-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.